Nitric Oxide (Donor/Induced) in Chemosensitization: Volume 1

ISBN-13: 9780128164716 / Angielski / Twarda / 2018 / 248 str.

Benjamin Bonavida

Spis treści

1. Nitric Oxide Mediated Chemosensitization: Gene Therapy Versus Exogenous Introduction of NO Donors2. Nitric Oxide Donors Sensitize Resistant Cancer Cells to Apoptosis Induced by Chemotherapy: Molecular Mechanisms of Sensitization3. RRx-001 Reset: Chemoresensitization Via NO-Mediated M1 Macrophage Repolarization4. Nitric Oxide and Nitric Oxide-Donors in Pre-Clinical Studies of Breast and Prostate Cancer5. Evaluation of the Impact of Nitric Oxide on Resistance to Platinum-Based Chemotherapeutics6. Nitric oxide and platinum derivatives-based regimens for cancer treatment: from preclinical studies to clinical trials7. NO-H₂S Releasing Chimeras as a Multifaceted Approach to Cancer Therapy8. Nitric Oxide-based Anticancer Therapeutics: The New Technologies of The Nanoparticles9. Nitric Oxide in Rectal Cancer: from Mice to Patients10. Chemoprotective and Chemosensitizing Effects of Nitric oxide and Other Biologically Active Gases in Breast Cancer Chemotherapy: Potential Implications11. Role of Nitric Oxide in Cancer Stem Cell Regulation and Metastasis 12. Nitric Oxide Interacting with Glutathione Transferases 13. Application of MRI to Study the Role of Nitric Oxide in Cancer Therapy14. S-Nitrosothiol Metabolism In Cancer And Therapeutic Implications

O autorze

Benjamin Bonavida, PhD, has been involved in the field of immunology and cancer biology for several decades and has published extensively in the fields of cancer resistance, chemotherapy, immunotherapy, and various molecular approaches to circumvent the resistance of the cancer cells using sensitizing agents. Accordingly, he was the first to publish a book on tumor sensitization in 2008. More recently, Dr. Bonavida is the Series Editor of 3 series published by Elsevier/Academic Press ("Cancer Sensitizing Agents for Chemotherapy,” "Breaking Cancer Resistance to Therapeutic Antibodies,” and "Breaking Tolerance to Anti-Cancer Immunotherapy”) and several books have been published and many are in development. He has published extensively in the field of NK biology and cytotoxicity in the past, and many of these publications were in collaboration with the co-editor Dr. Anahid Jewett.